Heavy sigh: AB 1990 moves to the Senate

California's AB 1990 – the so-called Consumer Protection Compounding Act – has passed the Assembly floor and is now heading to the Senate. If you need a refresher on why this bill matters: it would effectively ban compounded GLP-1s even during drug shortages and when personalization is medically necessary, impose manufacturing-style burdens that Congress intentionally excluded from pharmacy compounding, and restrict patient access to lawful, patient-specific care.

It doesn't target counterfeit drugs or illicit online sellers – it targets licensed, compliant pharmacies already subject to state and federal oversight.

APC has been in this fight from the start – appearing before the California Board of Pharmacy, pushing for an official opposed position, and running targeted digital ads making clear what this bill actually does versus what its proponents claim. The Trojan horse framing we've used isn't rhetorical flourish – it's an accurate description of legislation dressed up as consumer protection that would do real harm to patients.

The Senate is the next battleground, and we'll need your help with a specific call to action to share grassroots messaging directly with your patients and prescribers. When we ask, it'll matter.